(9Z,12Z,15Z)-N-Benzyloctadeca-9,12,15-trienamide

Catalog No. :
ACYEQM407
CAS No. :
883715-18-2
Molecular Formula :
C25H37NO
Molecular Weight :
367.58

IUPAC Name:(9Z,12Z,15Z)-N-benzyloctadeca-9,12,15-trienamide

(9Z,12Z,15Z)-N-Benzyloctadeca-9,12,15-trienamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$109.00Login to see priceInquiryInquiry
10mg98%$156.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(9Z,12Z,15Z)-N-Benzyloctadeca-9,12,15-trienamide
IUPAC Name(9Z,12Z,15Z)-N-benzyloctadeca-9,12,15-trienamide
MDL No.-
Molecular FormulaC25H37NO
Molecular Weight367.58
SMILESO=C(CCCCCCC/C=C\C/C=C\C/C=C\CC)NCC1=CC=CC=C1
InChI KeyVCMMYRWIEZCYDK-PDBXOOCHSA-N
Synonym60D4QDV5QG | BDBM50438779 | N-benzyllinolenamide | UNII-60D4QDV5QG | N-benzyl-9Z,12Z,15Z-octadecatrienamide | 9,12,15-Octadecatrienamide, N-(phenylmethyl)-, (9Z,12Z,15Z)- | n-benzyl-(9z,12z,15z)-octadecatrienamide | AKOS037515414 | LMFA08020159 | CS-00230
CAS No.883715-18-2
PubChem CID68741582

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYEQM407 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRWGB046 route compound structure diagram
    ACRWGB046463-40-1 In Stock
  2. Plus
  3. ACICYA027 route compound structure diagram
    ACICYA02737488-40-7 In Stock
  4. Then
  5. ACYEQM407 route product structure diagram
    ACYEQM407883715-18-2
Inquiry

2. ACYEQM407 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICYA027 route compound structure diagram
    ACICYA02737488-40-7 In Stock
  4. Then
  5. ACYEQM407 route product structure diagram
    ACYEQM407883715-18-2
Inquiry

Comments (0)